Use of histones for therapeutic purposes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8962562
APP PUB NO 20140148391A1
SERIAL NO

13758950

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of at least one human recombinant histone, especially at least one histone H1 subtype, and/or a therapeutic histone fraction as a basis for the treatment of thrombocytopenia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYMBIOTEC GENELLSCHAFT ZUR ERFORSCHUNG AUF DEM GEIBEIT DER BIOTECHNOLOGIE MBHSTUHLSATZENHAUSWEG 69 SAARBRUCKEN D-66123

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Class, Reiner London, GB 11 14
Zeppezauer, Michael Saarbruecken, DE 17 47

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 24, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00